WCA
BSX icon

Waratah Capital Advisors’s Boston Scientific BSX Stock Holding History

Waratah Capital Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-17,118
Closed -$856K – 155
2023
Q1 		$856K Sell
17,118
-4,975
-23% -$234K 0.02% 148
2022
Q4 		$1.02M Buy
+22,093
New +$957K 0.02% 151

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Waratah Capital Advisors's BSX Position: Q2 2023 in Review

Waratah Capital Advisors sold out of Boston Scientific (BSX) in Q2 2023, closing a stake of 17,118 shares — an estimated $856K sold.

Waratah Capital Advisors first reported a position in BSX in Q4 2022 and held it in 2 quarters. The position peaked at $1.02M in Q4 2022. 1,066 funds tracked by Wall St. Rank hold BSX as of Q2 2023.

  • Waratah Capital Advisors reported no remaining Boston Scientific position as of Q2 2023 after selling out during the quarter.
  • Waratah Capital Advisors sold 17,118 Boston Scientific shares in Q2 2023, an estimated $856K.
  • Waratah Capital Advisors first reported a position in Boston Scientific in Q4 2022 and held it in 2 quarters.
  • Waratah Capital Advisors's Boston Scientific position peaked at $1.02M in Q4 2022.
  • 1,066 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2023.

Based on Waratah Capital Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.